title: Idiopathic thrombocytopenic purpura: guidance amid uncertainty.
abstract: Clinical guidelines for treating ITP are based on the consensus of an expert panel, as randomized trials are lacking. Newer genetically engineered treatments hold promise but await definitive study.
authors.affiliation: Department of Hematology and Medical Oncology, Cleveland Clinic, USA.
authors.forename: A
authors.initials: A
authors.lastname: Lichtin
mesh_terms: D000328:Adult; D001772:Blood Cell Count; D001856:Bone Marrow Examination; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000628:therapy*; D012016:Reference Values; D013156:Splenectomy